4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001104659-17-062430
Options or other derivatives
- 10% owner bought 500,000 shares at $100.00 ($50,000,000)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. 10% owner | 2017-10-16 | Purchase · Series A Participating Convertible Preferred Shares | +500,000 | $100.00 | $50,000,000 | 500,000 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…